Follow an imaginary chain
Consider a fictional product said to influence a cellular pathway, improve tissue function, and reduce symptoms. Those are three separate links. Evidence for the first does not automatically establish the other two.
The effect might occur only at concentrations not reached in ordinary use. Another pathway might offset it. A measurable biological change might be too small to matter to how someone feels or functions. These possibilities are reasons to test the full claim, not reasons to assume the product cannot work.
Ask where the evidence stops
| Evidence described | Question still open |
|---|---|
| An effect in isolated cells | Does a comparable effect occur in people? |
| A change in a biomarker | Does it improve a meaningful health outcome? |
| Improvement after starting a product | Would improvement have occurred without it? |
| Benefit in a controlled trial | How does it compare with burdens and harms in the intended setting? |
The examples identify logical gaps. They do not imply that every useful treatment must have a fully understood mechanism before it can be evaluated.
The reverse mistake
An incomplete mechanistic explanation does not prove an intervention is ineffective. Reliable outcome evidence and mechanistic knowledge can develop at different speeds. The question “Does it help?” remains distinct from “Exactly how does it help?”
NCCIH's science-literacy materials address the difference between suggestive claims and evidence about health. When reading a product explanation, it helps to underline the measured result and circle the claimed benefit. If those refer to different outcomes, the article needs evidence connecting them. A detailed account of molecules can sound persuasive while leaving that connection unresolved.
